BioMedTracker is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Informa

Search

Drug Impact Events

Date Lead
Company
Event Type Approval
Change
Approval
Likelihood
2/23/18 KemPharm (KMPH) Apadaz for Acute Pain Subscribers Only Subscribers Only Subscribers Only
2/23/18 Bellicum Pharmaceuticals (BLCM) BPX-501 for Bone Marrow Transplant and Stem Cell Transplant Subscribers Only Subscribers Only Subscribers Only
2/23/18 Mallinckrodt (MNK) Stanate for Hyperbilirubinemia Subscribers Only Subscribers Only Subscribers Only
2/23/18 Shire (SHPG) Lanadelumab for Hereditary Angioedema (HAE) Subscribers Only Subscribers Only Subscribers Only
2/22/18 Novo Nordisk (NVO) Oral Semaglutide for Diabetes Mellitus, Type II Subscribers Only Subscribers Only Subscribers Only

Upcoming Catalysts

Expected
Date Range
Lead
Company
Drug Expected
Catalyst
02/26/18 Subscribers Only Subscribers Only Trial Data - Top-Line Results
02/27/18 Subscribers Only Subscribers Only Progress Update - Development Review
02/27/18 Subscribers Only Subscribers Only Trial Data - Updated Results
Now - 02/28/18 Subscribers Only Subscribers Only Regulatory - Approval Decision (Emerging Markets)
Now - 02/28/18 Subscribers Only Subscribers Only Regulatory - Approval Decision (Japan)